| Idorsia Pharmaceuticals Ltd - QUVIVIQ 25 mg, Filmtabletten | | 68481 | | 01 | | QUVIVIQ 25 mg | | Filmtabletten | | N05CJ03 | | | | 01.12.2022 | | |
| | Composition | | daridorexantum 25 mg ut daridorexanti hydrochloridum, mannitolum, cellulosum microcristallinum, povidonum K 30, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, glycerolum, talcum, E 171, E 172 (rubrum), E 172 (nigrum) pro compresso obducto corresp. natrium 0.655 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Daridorexantum | 25 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Nigrum) pro Compresso Obducto | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Glycerol | | | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Mannitol | | | | Povidonum K | 30 | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 10 | PR | PR | B | | Yes | | 002 | 30 | PR | PR | B | | Yes |
|
|
